Since inception, Aprendiis and its affiliates used a proprietary rare disease detection software platform called GENA™ (developed by SIVOTEC BioInformatics, Boca Raton, Florida) to drive improved genomic research and better healthcare. With the COVID-19 pandemic impacting the daily operations of our partners, we leveraged our existing business relationships to expand our product offerings to include new COVID-19 detection kits. We have available inventory and are making these kits available to medical professionals throughout Latin America, the Caribbean and the United States.
We are also actively searching for the right large-volume distribution partners in Latin America that will help us bring solutions quickly to the market. If you think your company might be the right fit, please visit our website or email us at [email protected].
Company’s Keywords:
<0
<
<2020
Your request has been submitted successfully.
Own or work here?